CAS: 156586-90-2 - Cedelizumab
Fórmula:Unspecified
- Sinónimos:
- Cedelizumab
- Immunoglobulin G4, anti-(human CD4 (antigen)) (human-mouse monoclonal OKTcdr4a complementary determining region-grafted γ4-chain), disulfide with human-mouse monoclonal OKTcdr4a complementary determining region-grafted κ-chain, dimer
- Immunoglobulin G 4, (human-mouse monoclonal OKTcdr4a complementary determining region-grafted γ-chain anti-human CD 4 antigen), disulfide with human-mouse monoclonal OKTcdr4a complementary determining region-grafted κ-chain, dimer
- RWJ 49004
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | Cedelizumab REF: TM-T82756CAS: 156586-90-2 | - - - | A consultar | Qui 24 Out 24 |
 | Cedelizumab REF: 3D-CLA1073CAS: 156586-90-2 | - - - | A consultar | Ter 05 Nov 24 |
Cedelizumab
CAS:156586-90-2
Cedelizumab (RWJ 49004), an IgG4 monoclonal antibody, selectively targets CD4 and exhibits immunosuppressant properties [1].
Cor e Forma:
Solid
Ref: TM-T82756
| 1mg | A consultar | ||
| 5mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 24 de Outubro de 2024
Ref: 3D-CLA1073
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 5 de Novembro de 2024
